Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Understanding why pancreatic ductal adenocarcinoma is so aggressive

Understanding why pancreatic ductal adenocarcinoma is so aggressive

A new tool to study and map the intricacies of intercellular signaling

A new tool to study and map the intricacies of intercellular signaling

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Mouse model helps track organism’s development from embryonic stage to adulthood

Mouse model helps track organism’s development from embryonic stage to adulthood

More cancer patients could benefit from CAR T-cell therapy, Moffitt study suggests

More cancer patients could benefit from CAR T-cell therapy, Moffitt study suggests

Harnessing the formation of natural killer–tumor cell immunological synapse to treat solid cancers

Harnessing the formation of natural killer–tumor cell immunological synapse to treat solid cancers

Scientists develop new method to synthesize cotylenin A

Scientists develop new method to synthesize cotylenin A

Finding new therapeutic strategies for aggressive T-cell acute lymphoblastic leukemia

Finding new therapeutic strategies for aggressive T-cell acute lymphoblastic leukemia

Indiana researchers identify new target for colorectal cancer immunotherapy

Indiana researchers identify new target for colorectal cancer immunotherapy

More selective elimination of leukemic and hematopoietic stem cells

More selective elimination of leukemic and hematopoietic stem cells

Innovative device could help treat babies with blood disorders

Innovative device could help treat babies with blood disorders

Cancer patients with COVID-19 more likely to die from the disease

Cancer patients with COVID-19 more likely to die from the disease

Antioxidant-rich foods can lower risk of infection in children with leukemia

Antioxidant-rich foods can lower risk of infection in children with leukemia

Drug combo for untreated CLL approved by FDA based on E1912 trial

Drug combo for untreated CLL approved by FDA based on E1912 trial

Kurome secures license to develop novel therapies for chemo-resistant cancer

Kurome secures license to develop novel therapies for chemo-resistant cancer

Researchers report promising new therapy for recurrent pediatric brain cancers

Researchers report promising new therapy for recurrent pediatric brain cancers

Researchers discover physiological mechanisms underlying pediatric B-ALL

Researchers discover physiological mechanisms underlying pediatric B-ALL

Study shows why MDS cells have a competitive advantage that supports disease progression

Study shows why MDS cells have a competitive advantage that supports disease progression

New review confirms effectiveness of MMR, MMRV and MMR+V vaccines

New review confirms effectiveness of MMR, MMRV and MMR+V vaccines

Using genome-wide CRISPR technology to identify leukemia's weakness

Using genome-wide CRISPR technology to identify leukemia's weakness

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.